506
Views
11
CrossRef citations to date
0
Altmetric
Reviews

Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladder

, MD & , MD PhD
Pages 1017-1027 | Published online: 26 Feb 2011

Bibliography

  • Abrams P, Cardozo L, Fall M, The standardization of terminology of lower urinary tract function: report from the standardization sub-committee of the international continence society. Neurourol Urodyn 2002;21:167-78
  • Abrams P, Artibani W, Cardozo L, Reviewing the ICS 2002 terminology report: the ongoing debate. Neurourol Urodyn 2009;28:287
  • Milsom I, Abrams P, Cardozo L, How widespread are the symptoms of an overactive bladder and how are they managed: a population-based prevalence study. BJU Int 2001;87:760-66
  • Stewart WF, Van Rooyen JB, Cundiff GW, Prevalence and burden of overactive bladder in the United States. World J Urol 2003;20:327-36
  • Chen GD, Lin TL, Hu SW, Prevalence and correlation of urinary incontinence and overactive bladder in Taiwanese women. Neurourol Urodyn 2003;22:109-17
  • Corcos J, Schick E. Prevalence of overactive bladder and incontinence in Canada. Can J Urol 2004;11:2278-84
  • Temml C, Heidler S, Ponholzer A, Prevalence of the overactive bladder syndrome by applying the international continence society definition. Eur Urol 2005;48:622-27
  • Homma Y, Yamaguchi O, Hayashi K, An epidemiological survey of overactive bladder symptoms in Japan. BJU Int 2005;96:1314-18
  • Teloken C, Caraver F, Weber FA, Overactive bladder: prevalence and implications in Brazil. Eur Urol 2006;49:1087-92
  • Yu HJ, Liu CY, Lee KL, Overactive bladder syndrome among community-dwelling adults in Taiwan: prevalence, correlates, perception, and treatment seeking. Urol Int 2006;77:327-33
  • Irwin DE, Milsom I, Hunskaar S, Population based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: the EPIC study. Eur Urol 2006;50:1306-15
  • Zhang W, Song Y, He X, Prevalence and risk factors of overactive bladder syndrome in Fuzhou Chinese women. Neurourol Urodyn 2006;25:717-21
  • Dmochowski RR, Newman DK. Impact of overactive bladder on women in the United States: results of a national survey. Curr Med Res Opin 2007;23:65-76
  • Finkelstein K, Glosner S, Sanchez RJ, Prevalence of probable overactive bladder in a private obstetrics and gynecology group practice. Curr Med Res Opin 2008;24:1083-90
  • Benner JS, Becker R, Fanning K, Bother related to bladder control and health care seeking behavior in adults in the United States. J Urol 2009;181:2591-98
  • Milsom I. Lower urinary tract symptoms in women. Curr Opin Urol 2009;19:337-41
  • Cisternas MG, Foreman AJ, Marshall TS, Estimating the prevalence and economic burden of overactive bladder among Medicare beneficiaries prior to Medicare part D coverage. Curr Med Res Opin 2009;25:911-19
  • Safarinejad M. Prevalence of the overactive bladder among Iranian women based on the international continence society definition: a population-based study. Int Urol Nephrol 2009;41:35-45
  • Odeyemi IAO, Dakin HA, O'Donnell RA, Epidemiology, prescribing patterns and resource use associated with overactive bladder in UK primary care. Int J Clin Pract 2006;60:949-58
  • Tikkinen KAO, Tammela TLJ, Rissanen AM, Is the prevalence of overactive bladder overestimated? A population-based study in Finland. PLos ONE 2007;2:e195
  • Choo MS, Ku JH, Lee JB, Cross-cultural differences for adapting overactive bladder symptoms: results of an epidemiologic survey in Korea. World J Urol 2007;25:505-11
  • Wennberg AL, Molander U, Fall M, A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women. Eur Urol 2009;55:783-91
  • Donaldson MMK, Thompson JR, Matthews RJ, The natural history of overactive bladder and stress urinary incontinence in older women in the community: a 3 year prospective cohort study. Neurourol Urodyn 2006;25:709-16
  • Coyne KS, Sexton CC, Thompson CL, The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden the Epidemiology of LUTS (EpiLUTS) study. BJU Int 2009;104:352-60
  • Fayyad AM, Hill SR, Jones G. Prevalence and risk factors for bothersome lower urinary tract symptoms in women with diabetes mellitus from hospital-based diabetes clinic. Int Urogynecol J 2009;20:1339-44
  • Whitcomb E, Lukacz ES, Lawrence JM, Prevalence and degree of bother from pelvic floor disorders in obese women. Int Urogynecol J 2009;20:289-94
  • Lowenstein L, Kenton K, Brubaker L, The relationship between obstructive sleep apnea, nocturia, and daytime overactive bladder syndrome in women. Am J Obstet Gynecol 2008;198:598. e1-598.e5
  • Oh SJ, Ku JH, Choo MS, Health-related quality of life and sexual function in women with stress urinary incontinence and overactive bladder. Int J Urol 2008;15:62-7
  • Coyne KS, Sexton CC, Irwin ED, The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: the EPIC study. BJU Int 2008;101:1388-95
  • Irwin DE, Milsom I, Reilly K, Overactive bladder is associated with erectile dysfunction and reduced sexual quality of life in men. J Sex Med 2008;5:2904-10
  • Irwin DE, Milsom I, Kopp Z, Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder. Eur Urol 2009;56:14-20
  • Morant S, Bloomfield G, Vats V, Increased sexual dysfunction in men with storage and voiding lower urinary tract symptoms. J Sex Med 2009;6:1103-10
  • Hu TW, Wagner TH, Bentkover JD, Estimated economic costs of overactive bladder in the United States. Urol 2003;61:1123-8
  • Irwin DE, Mungapen L, Milsom I, The economic impact of overactive bladder syndrome in six western countries. BJU Int 2008;103:202-9
  • Onukwugha E, Zuckerman IH, McNally D, The total economic burden of overactive bladder in the United States: a disease-specific approach. Am J Manag Care 2009;15:S90-7
  • Sexton CC, Coyne KS, Vats V, Impact of overactive bladder on work productivity in the United States: results from EpiLUTS. Am J Manag Care 2009;15:S98-107
  • Morant SV, Reilly K, Bloomfield GA, Diagnosis and treatment of lower urinary tract symptoms suggestive of overactive bladder and bladder outlet obstruction among men in general practice in the UK. Int J Clin Pract 2008;62:688-94
  • de Groat WC, Yoshimura N. Changes in afferent activity after spinal cord injury. Neurourol Urodyn 2010;29:63-76
  • Morrison J, Wen J, Kibble A. Activation of pelvic afferent nerves from the rat bladder during filling. Scand J Urol Nephrol Suppl 1999;201:73-5
  • Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci 2008;9:453-66
  • Habler HJ, Janig W, Koltzenburg M. Activation of unmyelinated afferent fibres by mechanical stimuli and inflammation of the urinary bladder in the cat. J Physiol 1990;425:545-62
  • Vizzard MA. Neurochemical plasticity and the role of neurotrophic factors in bladder reflex pathways after spinal cord injury. Prog Brain Res 2006;152:97-115
  • Bennett HL, Gustafsson JA, Keast JR. Estrogen receptor expression in lumbosacral dorsal root ganglion cells innervating the female rat urinary bladder. Auton Neurosci 2003;105:90-100
  • Forrest SL, Keast JR. Expression of receptors for glial cell line-derived neurotrophic factor family ligands in sacral spinal cord reveals separate targets of pelvic afferent fibers. J Comp Neurol 2008;506:989-1002
  • Klinger MB, Vizzard MA. The role of p75NTR in female rat urinary bladder with cyclophosphamide-induced cystitis. Am J Physiol Renal Physiol 2008;295:F1778-89
  • Chuang YC, Fraser MO, Yu Y, Analysis of the afferent limb of the vesicovascular reflex using neurotoxins, resiniferatoxin and capsaicin. Am J Physiol Regul Integr Comp Physiol 2001;281:R1302-10
  • Maggi CA, Giuliani S, Conte B, Prostanoids modulate reflex micturition by acting though capsaicin-sensitive afferents. Eur J Pharmacol 1988;145:105-12
  • Maggi CA. The dual, sensory and efferent function of the capsaicin-sensitive primary sensory nerves in the bladder and urethra. In: Maggi CA, editor, Nervous control of the urogenital system. Harwood Academic Publishers, London; 1993. p. 383-422
  • de Groat WC, Yoshimura N. Mechanisms underlying the recovery of lower urinary tract function following spinal cord injury. Prog Brain Res 2006;152:59-84
  • Yoshimura N. Bladder afferent pathway and spinal cord injury: possible mechanisms inducing hyperreflexia of the urinary bladder. Prog Neurobiol 1999;57:583-606
  • Geirsson G, Fall M, Sullivan L. Clinical and urodynamic effects of intravesical capsaicin treatment in patients with chronic traumatic spinal detrusor hyperrefexia. J Urol 1995;154:1825-9
  • Cruz F, Guimaraes M, Silva C, Desensitization of bladder sensory fibers by intravesical capsaicin has long lasting clinical and urodynamic effects in patients with hyperactive or hypersensitive bladder dysfunction. J Urol 1997;157:585-9
  • Kruse MN, Bray LA, de Groat WC. Influence of spinal cord injury on the morphology of bladder afferent and efferent neurons. J Auton Nerv Syst 1995;54:215-24
  • Zvarova K, Dunleavy JD, Vizzard MA. Changes in pituitary adenylate cyclase activating polypeptide expression in urinary bladder pathways after spinal cord injury. Exp Neurol 2005;192:46-59
  • Zinck ND, Rafuse VF, Downie JW. Sprouting of CGRP primary afferents in lumbosacral spinal cord precedes emergence of bladder activity after spinal injury. Exp Neurol 2007;204:777-90
  • Vizzard MA. Increased expression of spinal cord Fos protein induced by bladder stimulation after spinal cord injury. Am J Physiol Regul Integr Comp Physiol 2000;279:295-305
  • Apostolidis A, Popat R, Yiangou Y, Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 2005;174:977-82
  • Brady CM, Apostolidis A, Yiangou Y, P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin. Eur Urol 2004;46:247-53
  • Apostolidis A, Fowler CJ. The use of botulinum neurotoxin type A (BoNTA) in urology. J Neural Transm 2008;115:593-605
  • Steers WD. Pathophysiology of overactive bladder and urge urinary incontinence. Rev Urol 2002;4:S7-18
  • Yoshimura N, de Groat WC. Plasticity of Na+ channels in afferent neurons innervating rat urinary bladder following spinal cord injury. J Physiol 1997;503:269-76
  • Vizzard MA. Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction. Exp Neurol 2000;161:273-84
  • Satoshi S, Sasaki K, Igawa Y, Detrusor overactivity induced by increased levels of nerve growth factor in bladder afferent pathways in rats. Neurourol Urodyn 2003;22:375-7
  • Lamb K, Gebhart GF, Bielefeldt K. Increased nerve growth factor expression triggers bladder overactivity. J Pain 2004;5:150-6
  • Seki S, Sasaki K, Igawa Y, Suppression of detrusor-sphincter dyssynergia by immunoneutralization of nerve growth factor in lumbosacral spinal cord in spinal cord injured rats. J Urol 2004;171:478-82
  • Giannantoni A, di Stasi SM, Nardicchi V, Botulinum A toxin injection into the detrusor decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity. J Urol 2006;175:2341-2
  • Luo J, Busillo JM, Benovic JL. M3 muscarinic acetylcholine receptor-mediated signaling is regulated by distinct mechanisms. Mol Pharmacol 2008;74:338-47
  • Vlaskovska M, Kasakov L, Rong W, P2X3 knock-out mice reveal a major sensory role for urothelially released ATP. J Neurosci 2001;21:5670-7
  • Araki I, Du S, Kamiyama M, Over-expression of epithelial sodium channels in epithelium of human urinary bladder with outlet obstruction. Urology 2004;64:1255-60
  • Yoshida M, Masunaga K, Satoji Y, Basic and clinical aspects of non-neuronal acetylcholine: expression of non-neuronal acetylcholine in urothelium and its clinical significance. J Pharmacol Sci 2008;106:193-8
  • Kim JC, Park EY, Seo SI, Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J Urol 2006;175:1773-6
  • Speakman MJ, Brading AF, Gilpin CJ, Bladder outlet obstruction – a cause of denervation supersensitivity. J Urol 1987;138:1461-6
  • O'Reilly BA, Kosada AH, Chang TK, A quantitative analysis of purinoceptor expression in the bladders of patients with symptomatic bladder outlet obstruction. BJU Int 2001;87:617-22
  • Haferkamp A, Mundhenk J, Bastian PJ, Increased expression of connexin 43 in the overactive neurogenic detrusor. Eur Urol 2004;46:799-805
  • Mills IW, Greenland JE, McMurray G, Studies of the pathophysiology of idiopathic detrusor instability: the physiological properties of the detrusor smooth muscle and its pattern of innervation. J Urol 2000;163:646-51
  • Andersson KE. Antimuscarinics for treatment of overactive bladder. Lancet Neurol 2004;3:46-53
  • Drake MJ, Harvey IJ, Gillespie JI, Localized contractions in the normal human bladder and in urinary urgency. BJU Int 2005;95:1002-5
  • Downie JW, Armour JA. Mechanoreceptor afferent activity compared with receptor field dimensions and pressure changes in feline urinary bladder. Can J Physiol Pharmacol 1992;70:1457-67
  • Gillespie JI. A developing view of the origins of urgency: the importance of animal models. BJU Int 2005;96:22-8
  • Chapple CR, Patroneva A, Raines SR. Effect of an ATP sensitive potassium channel opener in subjects with overactive bladder: a randomized, double-blind, placebo-controlled study (ZD0947IL/0004). Eur Urol 2006;49:879-86
  • Green SA, Alon A, Ianus J, Efficacy and safety of a neurokinin-1 receptor antagonist in postmenopausal women with overactive bladder with urge urinary incontinence. J Urol 2006;176:2535-40
  • Deba A, Palea S, Rouget C, Involvement of beta(3)-adrenoceptors in mouse urinary bladder function: role in detrusor muscle relaxation and micturition reflex. Eur J Pharmacol 2009;618:76-83

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.